Skip to content

What is Ryeqo? | Treating uterine fibroids

Ryeqo is a medication used to treat women with moderate to severe symptoms of uterine fibroids. So what is Ryeqo? It is a combination of three active ingredients: relugolix, estradiol and norethisterone acetate. This combination helps manage heavy menstrual bleeding and other symptoms associated with uterine fibroids.

Ryeqo represents a significant advancement in the treatment of uterine fibroid. For women suffering from moderate to severe symptoms, Ryeqo provides a valuable option that can improve their quality of life and reduce the impact of fibroids on their daily activities. As always, patients should consult with their healthcare provider to determine if Ryeqo is the right choice for their individual needs.

What are Uterine Fibroids?

Uterine fibroids, also known as leiomyomas or myomas, are non-cancerous growths that develop in or on the uterus. They can vary in size, from undetectable by the human eye to large masses that can distort and enlarge the uterus. Although the exact cause of uterine fibroids is unknown, they are believed to be related to hormonal and genetic factors. Common symptoms include heavy menstrual bleeding, prolonged periods, pelvic pain, frequent urination and complications during pregnancy and labour.

What is Ryeqo?

Ryeqo combines three active ingredients, each serving a specific purpose in the management of uterine fibroids:

1. Relugolix: This is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It works by decreasing the levels of oestrogen and progesterone in the body, hormones that can promote the growth of fibroids. By reducing these hormone levels, relugolix helps shrink the fibroids and alleviate associated symptoms.

2. Estradiol: A form of oestrogen, estradiol is included in the combination to counteract the potential side effects of low oestrogen levels caused by relugolix. These side effects can include hot flushes, night sweats and a decrease in bone mineral density. By maintaining a certain level of oestrogen, estradiol helps to mitigate these issues.

3. Norethisterone Acetate: This is a synthetic form of progesterone. It helps to maintain the beneficial effects of estradiol while also supporting menstrual cycle regulation. Norethisterone acetate further ensures that the hormonal balance needed for effective treatment is maintained.

How Ryeqo Works

Ryeqo works by targeting the hormonal imbalances that contribute to the growth of uterine fibroids. The relugolix component reduces the levels of oestrogen and progesterone, hormones that are known to stimulate the growth of fibroids. By lowering these hormone levels, the growth of fibroids is slowed, and their size can be reduced. This leads to a decrease in symptoms such as heavy menstrual bleeding and pelvic pain.

Estradiol and norethisterone acetate are included to ensure that the reduction in oestrogen and progesterone does not lead to other health issues. Estradiol helps prevent symptoms associated with low oestrogen levels, while norethisterone acetate supports overall hormonal balance and menstrual cycle regulation.

Administration and Dosage

Ryeqo is typically administered orally, with the dosage prescribed by a healthcare provider based on the individual needs of the patient. It is important for patients to follow their healthcare provider’s instructions carefully to ensure the medication is effective and to minimise potential side effects.

Potential Side Effects

As with any medication, Ryeqo can have side effects. Common side effects include hot flushes, night sweats, headaches and mood swings. More serious side effects can occur but are less common. It is important for patients to discuss any concerns with their healthcare provider and to report any unusual symptoms promptly.

Effectiveness and Benefits

Clinical trials have demonstrated the effectiveness of Ryeqo in reducing symptoms of uterine fibroids. Many women experience a significant reduction in heavy menstrual bleeding, less pelvic pain and an overall improvement in quality of life. Additionally, Ryeqo provides a non-surgical treatment option for women who wish to manage their fibroid symptoms without undergoing invasive procedures.

Dr. Ed Gomez can provide further assistance and guidance in navigating uterine fibroids and discussing if Ryeqo is right for you. Contact his rooms today.

What is Ryeqo? | Treating uterine fibroids
Dr Ed Gomez is proud to be a member and affiliated with

Contact us

General Enquiries
Telephone: 1800 961 456

6 Kempsey Street,
Blacktown NSW 2148
Tel: (02) 9622 8000
Fax: (02) 9622 8686

Suite 4.03, Level 4
17 Macquarie Street,
Parramatta NSW 2150
Tel: (02) 7809 0947
Fax: (02) 7809 0946